Literature DB >> 21326171

Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.

Krzysztof Kiryluk1, Zina Moldoveanu, John T Sanders, T Matthew Eison, Hitoshi Suzuki, Bruce A Julian, Jan Novak, Ali G Gharavi, Robert J Wyatt.   

Abstract

Serum galactose-deficient immunoglobulin A1 (Gd-IgA1) is an inherited risk factor for adult IgA nephropathy (IgAN). In this paper, we determined the heritability of serum Gd-IgA1 levels in children with IgAN and Henoch-Schönlein purpura nephritis (HSPN), two disorders with clinical phenotypes sharing common pathogenic mechanisms. Serum Gd-IgA1 concentrations were quantified using a Helix aspersa-lectin-based enzyme-linked immunosorbent assay. As a group, 34 children with either disorder (20 with HSPN and 14 with IgAN) had significantly higher Gd-IgA1 levels compared with 51 age- and ethnicity-matched pediatric controls. Serum levels of Gd-IgA1 were also elevated in a large fraction of 54 first-degree relatives of pediatric IgAN and HSPN patients compared with 141 unrelated healthy adult controls. A unilineal transmission of the trait was found in 17, bilineal transmission in 1, and sporadic occurrence in 5 of 23 families when both parents and the patient were analyzed. There was a significant age-, gender-, and household-adjusted heritability of serum galactose-deficient IgA1 estimated at 76% in pediatric IgAN and at 64% in HSPN patients. Thus, serum galactose-deficient IgA1 levels are highly inherited in pediatric patients with IgAN and HSPN, providing support for another shared pathogenic link between these disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21326171      PMCID: PMC3641561          DOI: 10.1038/ki.2011.16

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  43 in total

1.  Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

Authors:  Ali G Gharavi; Zina Moldoveanu; Robert J Wyatt; Catherine V Barker; Susan Y Woodford; Richard P Lifton; Jiri Mestecky; Jan Novak; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

2.  Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

Authors:  Hitoshi Suzuki; Run Fan; Zhixin Zhang; Rhubell Brown; Stacy Hall; Bruce A Julian; W Winn Chatham; Yusuke Suzuki; Robert J Wyatt; Zina Moldoveanu; Jeannette Y Lee; James Robinson; Milan Tomana; Yasuhiko Tomino; Jiri Mestecky; Jan Novak
Journal:  J Clin Invest       Date:  2009-05-26       Impact factor: 14.808

3.  The impact of pedigree structure on heritability estimates.

Authors:  Claus Thorn Ekstrøm
Journal:  Hum Hered       Date:  2009-07-22       Impact factor: 0.444

4.  Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.

Authors:  Xiaojie Lin; Jiaxiang Ding; Li Zhu; Sufang Shi; Lei Jiang; Minghui Zhao; Hong Zhang
Journal:  Nephrol Dial Transplant       Date:  2009-06-16       Impact factor: 5.992

5.  IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

Authors:  Hitoshi Suzuki; Zina Moldoveanu; Stacy Hall; Rhubell Brown; Huong L Vu; Lea Novak; Bruce A Julian; Milan Tomana; Robert J Wyatt; Jeffrey C Edberg; Graciela S Alarcón; Robert P Kimberly; Yasuhiko Tomino; Jiri Mestecky; Jan Novak
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

6.  Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.

Authors:  Sachiko Shimozato; Yoshiyuki Hiki; Hiroko Odani; Kazuo Takahashi; Kouichiro Yamamoto; Satoshi Sugiyama
Journal:  Nephrol Dial Transplant       Date:  2008-01-04       Impact factor: 5.992

Review 7.  The genetics of IgA nephropathy.

Authors:  Isabel Beerman; Jan Novak; Robert J Wyatt; Bruce A Julian; Ali G Gharavi
Journal:  Nat Clin Pract Nephrol       Date:  2007-06

Review 8.  Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Authors:  J Mestecky; M Tomana; Z Moldoveanu; B A Julian; H Suzuki; K Matousovic; M B Renfrow; L Novak; R J Wyatt; J Novak
Journal:  Kidney Blood Press Res       Date:  2008-01-08       Impact factor: 2.687

9.  Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

Authors:  Z Moldoveanu; R J Wyatt; J Y Lee; M Tomana; B A Julian; J Mestecky; W-Q Huang; S R Anreddy; S Hall; M C Hastings; K K Lau; W J Cook; J Novak
Journal:  Kidney Int       Date:  2007-03-07       Impact factor: 10.612

10.  Increasing heritability of BMI and stronger associations with the FTO gene over childhood.

Authors:  Claire M A Haworth; Susan Carnell; Emma L Meaburn; Oliver S P Davis; Robert Plomin; Jane Wardle
Journal:  Obesity (Silver Spring)       Date:  2008-10-09       Impact factor: 5.002

View more
  84 in total

Review 1.  IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.

Authors:  Jing Xue; Li-Ping Zhu; Qiang Wei
Journal:  Glycoconj J       Date:  2013-06-20       Impact factor: 2.916

Review 2.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

3.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

Review 4.  IgA Nephropathy.

Authors:  Jennifer C Rodrigues; Mark Haas; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

5.  Intestinal Microbiota and Kidney Diseases.

Authors:  Ao Xie; Jie Sheng; Feng Zheng
Journal:  Chin J Integr Med       Date:  2018-04-12       Impact factor: 1.978

6.  Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.

Authors:  Ke Xu; Lili Zhang; Jie Ding; Suxia Wang; Baige Su; Huijie Xiao; Fang Wang; Xuhui Zhong; Yanming Li
Journal:  J Nephrol       Date:  2017-11-28       Impact factor: 3.902

7.  A clinicopathological comparison between IgA nephropathy and Henoch-Schönlein purpura nephritis in children: use of the Oxford classification.

Authors:  Xueqian Li; Mengmeng Tang; Xingfeng Yao; Nan Zhang; Jianfeng Fan; Nan Zhou; Qiang Sun; Zhi Chen; Qun Meng; Lei Lei; Hejia Zhang; Chen Ling; Lin Hua; Xiangmei Chen; Xiaorong Liu
Journal:  Clin Exp Nephrol       Date:  2019-08-29       Impact factor: 2.801

Review 8.  Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.

Authors:  Krzysztof Kiryluk; Jan Novak; Ali G Gharavi
Journal:  Annu Rev Med       Date:  2012-10-16       Impact factor: 13.739

Review 9.  Vasculitis: do we know more to classify better?

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

10.  Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.

Authors:  Francois Berthoux; Hitoshi Suzuki; Lise Thibaudin; Hiroyuki Yanagawa; Nicolas Maillard; Christophe Mariat; Yasuhiko Tomino; Bruce A Julian; Jan Novak
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.